Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- Latest CDC Findings: A Wake‑Up Call for the $1.3 Billion Global Sepsis Diagnostics Market April 6, 2026
- NAMs, NIH Policy, and What it Means for Diagnostics March 20, 2026
- As Flu Outpaces COVID This Winter, Rapid Molecular Testing Takes on New Importance March 17, 2026
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
VIDEO: 5 Key Facts about Point-of-Care (POC) Diagnostic Tests
Learn about these 5 key facts based on research featured in The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition (published April 2022), a recent report by Kalorama Information Watch the one minute video below for insights and important facts regarding the POC diagnostic testing market. And as always, Kalorama Information offers even more […]
AACC Calls on Congress to Halt Legislation That Would Hinder Patient Access to Essential Medical Tests
WASHINGTON – AACC has sent comments to the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee urging the committee not to include the VALID Act in its omnibus Food and Drug Administration (FDA) user fee legislation. VALID would limit the availability of vital laboratory-developed tests, decreasing patient access to life-saving diagnostic tools. View the comments […]
This Week in Cell and Gene Therapy: 14 New Developments to Know (May 23, 2022)
Pandemic Pushes Rx To OTC Switches
The U.S. Rx-to-OTC market has grown into a $13,807 million ($13.8 billion) market, according to 2021 estimates by leading medical market researcher Kalorama Information in the new report The Market for Rx-to-OTC Switches, 8th Edition. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, the FDA willingness […]
This week in Cell and Gene Therapy: 14 New Developments to Know (May 9, 2022)
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. The U.S. FDA has lifted clinical holds on two Phase III clinical studies evaluating gene therapies being developed by Pfizer, based in New York, NY. On April 28th, Pfizer announced […]
COVID-19 Test Market: $33BN in Revenues in 2021, Future Still a Guess
Kalorama has just completed a report on the COVID-19 in vitro diagnostic testing market. 2021 was a year in which point-of-care antigen tests, lab-based PCR tests, rapid PCR and even home tests were available to the market. Also antibody tests, NGS tests and other tests were brought to bear in diagnosing cases. The scourge of […]
Point-of-Care (POC) Diagnostic Testing: 5 Key Trends to Watch from 2022-2026
Globally, millions of dollars are spent annually on point-of-care (POC) diagnostic testing, both professional testing (which includes physician office labs, clinic labs, employer labs and hospital labs) and self-testing (which includes home, drug store testing and continuous glucose testing). In 2021, amidst the pandemic, the POC market reached $41,149 million ($41.1 billion) and the market […]
At-Home Diagnostic Testing: COVID-19 Has Consumers More Comfortable with Tests for Infectious Diseases
The global at-home in vitro diagnostics (IVD) testing market had sales of $20.5 billion in 2021, up more than 35% from the previous year, largely due to increased testing in the infectious disease segment. Glucose testing and COVID-19 testing accounted for the majority of sales, according to leading medical market researcher Kalorama Information in the […]
12 Recent Developments in Cell and Gene Therapy as of April 22, 2022
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. In public offering news, Massachusetts-based Selecta Biosciences has announced a $38.7 million public offering to continue developing ImmTOR, its antigen-specific immune tolerance platform. Leading the private financing news, Cambridge-based cell […]
106 Billion IVD Procedures and Counting
“Medical market researcher Kalorama Information forecasts exponential growth in both in vitro diagnostics (IVD) procedures and sales between 2021 and 2026.” The global in vitro diagnostics (IVD) procedures market continues to grow off momentum originating at the height of the pandemic and lingering on today. There are currently 106,624 million (106 billion) in vitro […]